T cell-inducing vaccine durably prevents mucosal SHIV infection even with lower neutralizing antibody titers

Journal: Nature Medicine

Published: 2020-05-11

DOI: 10.1038/s41591-020-0858-8

Affiliations: 22

Authors: 34

Go to article
Institutions Share
Emory Vaccine Center (EVC), Emory University, United States of America (USA) 0.15
Division of Microbiology and Immunology, Emory University, United States of America (USA) 0.11
Stanford Institute for Immunity, Transplantation and Infection (ITI), United States of America (USA) 0.10
Department of Microbiology and Immunology, Cornell University, United States of America (USA) 0.06
3M Company, United States of America (USA) 0.06
Department of Bioengineering (BE), UC San Diego, United States of America (USA) 0.06
BioLegend, Inc., United States of America (USA) 0.06
Department of Microbiology, Immunology and Parasitology, LSU, United States of America (USA) 0.06
Duke Department of Surgery, United States of America (USA) 0.06
Department of Pathology and Laboratory Medicine, Emory University, United States of America (USA) 0.05
Emory Yerkes National Primate Research Center, United States of America (USA) 0.05
Center for Immunology (CFI), UMN, United States of America (USA) 0.04
Department of Microbiology and Immunology, UMN, United States of America (USA) 0.04
Stanford Center for Biomedical Informatics Research (BMIR), United States of America (USA) 0.03
Department of Medicine, Penn, United States of America (USA) 0.03
Department of Microbiology and Immunology, UWO, Canada 0.03
Stanford Department of Pathology, United States of America (USA) 0.01
Stanford Department of Microbiology and Immunology, United States of America (USA) 0.01

Return

Except where otherwise noted © 2021 Springer Nature Limited. All Rights Reserved.
partner of AGORA, HINARI, OARE, INASP, ORCID, CrossRef and COUNTER